10 March 2023 - By law, Medicare will have to take a medication’s efficacy and its research and development costs ...
3 March 2023 - PHARMAC will hear from people affected by rare disorders in its upcoming Rare Disorders Advisory Committee meeting ...
8 February 2023 - A process brought in to streamline decision-making around access to new medicines in NHSScotland during the ...
4 February 2023 - The mission of NICE is to get the best care to patients fast, while ensuring value for ...
5 January 2023 - The main objective of this study was to explore the extent to which the incremental cost effectiveness ...
12 December 2022 - The measurement and valuation of child health-related quality of life is a rapidly evolving field. ...
2 November 2022 - Advances in the digitisation of health systems and expedited regulatory approvals of innovative treatments have led to ...
20 October 2022 - Patient engagement in health technology assessment has become increasingly important over the past 20 years. ...
15 September 2022 - Following on from this week's article on early re-entry resubmissions, today we took a close look ...
8 September 2022 - It is ideal that modelling studies apply health utility values that are compatible, derived using common methods, ...
8 September 2022 - To assess the clinical relevance of patient reported outcomes, a response threshold of ≥ 15% of the ...
8 September 2022 - The decision by the UK National Institute for Health and Care Excellence not to recommend esketamine ...
8 September 2022 - When drug-buying agency PHARMAC switched to a cheaper vaccine covering fewer strains of potentially deadly pneumococcal ...
7 September 2022 - Every time I read about clinical trials testing possible treatments for rare diseases, I think of ...
6 September 2022 - The Institute of Cancer Research, London, has expressed disappointment that NICE has confirmed its decision not ...